Loading
IARC estimates 9,983 new cancer cases and 6,155 cancer deaths in Somalia in 2024; the commonest new cancers are breast, cervix uteri and colorectum. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Somalia's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,979 | 36.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 1,089 | 22.3 | Cervical cancer |
| Colorectum | 781 | 8.8 | Colorectal cancer |
| Prostate | 734 | 22.6 | Prostate cancer |
| Oesophagus | 450 | 5.6 | Oesophageal cancer |
| Leukaemia | 417 | 2.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Stomach | 309 | 3.7 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 281 | 3.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Non-Hodgkin lymphoma | 263 | 2.2 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Liver and intrahepatic bile ducts | 236 | 2.6 | Hepatocellular carcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 930 | 18.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 665 | 13.9 | Cervical cancer |
| Prostate | 445 | 13.9 | Prostate cancer |
| Colorectum | 442 | 5.3 | Colorectal cancer |
| Oesophagus | 416 | 5.2 | Oesophageal cancer |
| Leukaemia | 277 | 2.0 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 253 | 3.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Stomach | 251 | 3.1 | Gastric & gastro-oesophageal junction cancer |
| Liver and intrahepatic bile ducts | 216 | 2.4 | Hepatocellular carcinoma |
| Brain, central nervous system | 174 | 1.5 | Glioma & glioblastoma |
No trial record in OnCo lists a site in Somalia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Somalia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Somalia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Somalia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.